Lista de obras - Jack Moye - Dominio Público Uruguay

Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1-infected children in resource-poor settings

artículo científico publicado en 2003

Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women

artículo científico publicado en 2009

Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection

artículo científico publicado en 2005

Associations of proinflammatory cytokine levels with lipid profiles, growth, and body composition in HIV-infected children initiating or changing antiretroviral therapy

artículo científico publicado en 2010

Blood culture in the first 6 months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection. The Women and Infants Transmission Study Group.

artículo científico publicado en 1994

Combination Nucleoside Analog Reverse Transcriptase Inhibitor(s) Plus Nevirapine, Nelfinavir, or Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: Week 24 Results of a Randomized Controlled Trial - PACTG 377

article

Combined evaluation of sexually transmitted infections in HIV-infected pregnant women and infant HIV transmission

artículo científico publicado en 2018

Congenital CMV and HIV Perinatal Transmission.

artículo científico publicado en 2018

Consenting postpartum women for use of routinely collected biospecimens and/or future biospecimen collection

artículo científico publicado en 2016

Current Issues in the Immunoprophylaxis of Vertical Transmission of HIV

article

Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital Cytomegalovirus Infection

artículo científico publicado en 2017

Diminished human immunodeficiency virus type 1 DNA yield from dried blood spots after storage in a humid incubator at 37 degrees C compared to -20 degrees C

artículo científico publicado en 2008

Endocrine abnormalities and impaired growth in human immunodeficiency virus-infected children

artículo científico publicado en 2007

Erratum to “Mapping placental topology from 3D scans, the graphic display of variation in arborisation across gestation” [Placenta 34 (2013) A73–A74]

scholarly article published in Placenta

Exploring the associations between microRNA expression profiles and environmental pollutants in human placenta from the National Children's Study (NCS)

artículo científico publicado en 2015

Gastrointestinal disorders

article

Gender differences in lymphocyte populations, plasma HIV RNA levels, and disease progression in a cohort of children born to women infected with HIV.

artículo científico publicado en 2006

Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy

artículo científico publicado en 2005

Growth, nutrition, and metabolism

Infectious Morbidity, Mortality and Nutrition in HIV-Exposed, Uninfected, Formula Fed Infants: Results from the HPTN 040/PACTG 1043 Trial.

artículo científico publicado en 2018

Insulin-like growth factor-1 and lean body mass in HIV-infected children

artículo científico publicado en 2008

Interventions to prevent vertical transmission of HIV-1: effect on viral detection rate in early infant samples

article

Iodine status in pregnant women in the National Children's Study and in U.S. women (15-44 years), National Health and Nutrition Examination Survey 2005-2010

artículo científico publicado en 2013

Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy

artículo científico publicado en 2008

Lymphocyte Phenotyping in Infants: Maturation of Lymphocyte Subpopulations and the Effects of HIV Infection

artículo científico publicado en 1997

Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis

artículo científico publicado en 2004

Morphologic and metabolic abnormalities in vertically HIV-infected children and youth

artículo científico publicado en 2009

Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group.

artículo científico publicado en 1996

Nelfinavir and Lamivudine pharmacokinetics during the first two weeks of life

artículo científico publicado en 2011

Nevirapine concentrations in newborns receiving an extended prophylactic regimen

artículo científico publicado en 2008

Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO 542) observed in HIV-1-infected children

artículo científico publicado en 2007

Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1.

artículo científico publicado en 2002

Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection

artículo científico publicado en 2003

Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life

artículo científico publicado en 2005

Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: Results of Pediatric AIDS Clinical Trials Study 402

article

Planned multiple exposures to autologous virus in HIV type 1-infected pediatric populations increases HIV-specific immunity and reduces HIV viremia

artículo científico publicado en 2008

Planned variation in preanalytical conditions to evaluate biospecimen stability in the National Children's Study (NCS).

artículo científico publicado en 2013

Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV

artículo científico publicado en 2010

Predictors of growth and body composition in HIV-infected children beginning or changing antiretroviral therapy

artículo científico publicado en 2010

Prenatal mercury concentration is associated with changes in DNA methylation at TCEANC2 in newborns

artículo científico publicado en 2015

Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglo

artículo científico publicado en 1992

Randomized controlled trial of feeding a concentrated formula to infants born to women infected by human immunodeficiency virus

artículo científico publicado en 2009

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

artículo científico publicado en 1999

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection

artículo científico publicado en 2003

Safety and immunogenicity of early measles vaccination in children born to HIV-infected mothers in the United States: results of Pediatric AIDS Clinical Trials Group (PACTG) protocol 225.

artículo científico publicado en 2011

Selected persistent organic pollutants in human placental tissue from the United States

scientific article published on 31 January 2014

Steady-state pharmacokinetics of lopinavir/ritonavir in combination with efavirenz in human immunodeficiency virus-infected pediatric patients

artículo científico publicado en 2009

Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia

artículo científico publicado en 2008

Success rates for consent and collection of prenatal biological specimens in an epidemiologic survey of child health

artículo científico publicado en 2016

Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140)

article

The use of human tissues in research: what do we owe the research subjects?

artículo científico publicado en 2011

Three Postpartum Antiretroviral Regimens to Prevent Intrapartum HIV Infection

article

Three postpartum antiretroviral regimens to prevent intrapartum HIV infection

artículo científico publicado en 2012

Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045.

artículo científico publicado en 2010

Urinary concentrations of environmental phenols in pregnant women in a pilot study of the National Children's Study

artículo científico publicado en 2014

Zidovudine, Didanosine, or Both as the Initial Treatment for Symptomatic HIV-Infected Children

article

Lista de obras de Jack Moye

Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1-infected children in resource-poor settings

Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women

Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection

Associations of proinflammatory cytokine levels with lipid profiles, growth, and body composition in HIV-infected children initiating or changing antiretroviral therapy

Blood culture in the first 6 months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection. The Women and Infants Transmission Study Group.

Combination Nucleoside Analog Reverse Transcriptase Inhibitor(s) Plus Nevirapine, Nelfinavir, or Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: Week 24 Results of a Randomized Controlled Trial - PACTG 377

Combined evaluation of sexually transmitted infections in HIV-infected pregnant women and infant HIV transmission

Congenital CMV and HIV Perinatal Transmission.

Consenting postpartum women for use of routinely collected biospecimens and/or future biospecimen collection

Current Issues in the Immunoprophylaxis of Vertical Transmission of HIV

Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital Cytomegalovirus Infection

Diminished human immunodeficiency virus type 1 DNA yield from dried blood spots after storage in a humid incubator at 37 degrees C compared to -20 degrees C

Endocrine abnormalities and impaired growth in human immunodeficiency virus-infected children

Erratum to “Mapping placental topology from 3D scans, the graphic display of variation in arborisation across gestation” [Placenta 34 (2013) A73–A74]

Exploring the associations between microRNA expression profiles and environmental pollutants in human placenta from the National Children's Study (NCS)

Gastrointestinal disorders

Gender differences in lymphocyte populations, plasma HIV RNA levels, and disease progression in a cohort of children born to women infected with HIV.

Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy

Growth, nutrition, and metabolism

Infectious Morbidity, Mortality and Nutrition in HIV-Exposed, Uninfected, Formula Fed Infants: Results from the HPTN 040/PACTG 1043 Trial.

Insulin-like growth factor-1 and lean body mass in HIV-infected children

Interventions to prevent vertical transmission of HIV-1: effect on viral detection rate in early infant samples

Iodine status in pregnant women in the National Children's Study and in U.S. women (15-44 years), National Health and Nutrition Examination Survey 2005-2010

Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy

Lymphocyte Phenotyping in Infants: Maturation of Lymphocyte Subpopulations and the Effects of HIV Infection

Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis

Morphologic and metabolic abnormalities in vertically HIV-infected children and youth

Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group.

Nelfinavir and Lamivudine pharmacokinetics during the first two weeks of life

Nevirapine concentrations in newborns receiving an extended prophylactic regimen

Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO 542) observed in HIV-1-infected children

Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1.

Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection

Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life

Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: Results of Pediatric AIDS Clinical Trials Study 402

Planned multiple exposures to autologous virus in HIV type 1-infected pediatric populations increases HIV-specific immunity and reduces HIV viremia

Planned variation in preanalytical conditions to evaluate biospecimen stability in the National Children's Study (NCS).

Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV

Predictors of growth and body composition in HIV-infected children beginning or changing antiretroviral therapy

Prenatal mercury concentration is associated with changes in DNA methylation at TCEANC2 in newborns

Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglo

Randomized controlled trial of feeding a concentrated formula to infants born to women infected by human immunodeficiency virus

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection

Safety and immunogenicity of early measles vaccination in children born to HIV-infected mothers in the United States: results of Pediatric AIDS Clinical Trials Group (PACTG) protocol 225.

Selected persistent organic pollutants in human placental tissue from the United States

Steady-state pharmacokinetics of lopinavir/ritonavir in combination with efavirenz in human immunodeficiency virus-infected pediatric patients

Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia

Success rates for consent and collection of prenatal biological specimens in an epidemiologic survey of child health

Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140)

The use of human tissues in research: what do we owe the research subjects?

Three Postpartum Antiretroviral Regimens to Prevent Intrapartum HIV Infection

Three postpartum antiretroviral regimens to prevent intrapartum HIV infection

Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045.

Urinary concentrations of environmental phenols in pregnant women in a pilot study of the National Children's Study

Zidovudine, Didanosine, or Both as the Initial Treatment for Symptomatic HIV-Infected Children